The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Reference-Cited by-同舟云学术

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

Published:2020-10-19 Issue:12 Volume:18 Page:3163-3168
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Toorop Myrthe M. A.¹^ORCID,Lijfering Willem M.¹^ORCID,Scheres Luuk J. J.¹²

Affiliation:

1. Department of Clinical Epidemiology Leiden University Medical Center Leiden The Netherlands

2. Department of Internal Medicine Radboud University Medical Center Nijmegen The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15104

Reference46 articles.

1. National Trends in Ambulatory Oral Anticoagulant Use

2. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

3. Antithrombotic Therapy for VTE Disease

4. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

5. Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. Oral rivaroxaban for symptomatic venous thromboembolism;EINSTEIN Investigators BR;N Engl J Med,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis;Thrombosis Research;2024-10

2. Laboratory Monitoring of Direct Oral Anticoagulants;Anticoagulation - An Update [Working Title];2023-12-07

3. Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants;Rational Pharmacotherapy in Cardiology;2023-07-27

4. Impact of Direct Oral Anticoagulant Concentration on Clinical Outcomes in Asian Patients with Atrial Fibrillation;Clinical Pharmacology & Therapeutics;2023-05-17

5. Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment;CNS Drugs;2023-03